Sonoma BioTherapeutics Funding: $40M Raised, Series A (2020)
Sonoma BioTherapeutics is based in Seattle, WA. It has raised $40M in total funding. Latest round: Series A.
Sonoma BioTherapeutics funding overview
Sonoma BioTherapeutics is based in Seattle, WA. Sonoma BioTherapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2020. The round record for Sonoma BioTherapeutics runs through 2020; nothing later has been disclosed. Investors on record include Lyell Immunopharma, ARCH Venture Partners, Milky Way Ventures, 8VC. 4 distinct backers are named across the disclosed rounds.
Sonoma BioTherapeutics at a glance
Total raised
$40M
Latest round
Series A
Latest round date
February 2020
Headquarters
Seattle, WA
Notable investors
Lyell Immunopharma, ARCH Venture Partners, Milky Way Ventures, 8VC
Frequently asked about Sonoma BioTherapeutics funding
How much has Sonoma BioTherapeutics raised?
Sonoma BioTherapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Sonoma BioTherapeutics?
Lyell Immunopharma, ARCH Venture Partners, Milky Way Ventures, 8VC are named among the investors backing Sonoma BioTherapeutics.
What was the latest Sonoma BioTherapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2020.
Where is Sonoma BioTherapeutics based?
Sonoma BioTherapeutics is based in Seattle, WA.
When did Sonoma BioTherapeutics last raise?
The last disclosed Sonoma BioTherapeutics round closed in February 2020 at Series A.
We update the Sonoma BioTherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seattle and their backers are listed below.
